PAVmed Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $71,000 | $3.0M | $2.5M | $377,000 | $500,000 |
| Gross profit | — | — | — | — | -$85,000 |
| Operating income | -$21.8M | -$44.5M | -$68.8M | -$91.1M | -$54.4M |
| Operating expenses | — | — | — | — | $54.3M |
| Cost of revenue | $218,000 | $4.8M | $6.4M | $3.6M | $585,000 |
| Cash from operations | -$5.2M | -$33.6M | -$52.0M | -$71.0M | -$40.6M |
| Capital expenditure | $31,000 | $55,000 | $242,000 | $1.5M | $1.5M |
| Free cash flow | -$5.2M | -$33.6M | -$52.3M | -$72.5M | -$42.1M |
| Total assets | $38.8M | $30.7M | $33.1M | $54.0M | $87.0M |
| Total liabilities | $16.5M | $37.7M | $57.1M | $43.0M | $7.6M |
| Total debt | $7.8M | $25.2M | $44.2M | $33.6M | — |
Shares outstanding 7.3M · Free float 47.4%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.